Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 5/20 | 0.60 |
| ▸ | RAB9A | P51151 | 8/20 | 0.56 |
| ▸ | NPC1 | O15118 | 6/20 | 0.56 |
| ▸ | NCOA3 | Q9Y6Q9 | 2/20 | 0.56 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.52 |
| ▸ | HTT | P42858 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.52 |
| ▸ | MITF | O75030 | 2/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12720926 | 0.84 | NPC1 (0.60) | AGTR1RAB9ANPC1SMN1; SMN2HTT | |
| SCHEMBL12720931 | 0.82 | SMN1; SMN2 (0.46) | AGTR1RAB9ANPC1SMN1; SMN2HTT | |
| SCHEMBL12720823 | 0.82 | AGTR1 (0.88) | AGTR1RAB9ANPC1NCOA3NCOA1 | |
| SCHEMBL12720938 | 0.81 | KMT2A (0.54) | AGTR1RAB9ANPC1SMN1; SMN2HTT | |
| SCHEMBL12720966 | 0.80 | KDM4E (0.55) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL12720952 | 0.80 | KDM4E (0.55) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL27178069 | 0.76 | AGTR1 (1.00) | AGTR1RAB9ANPC1NCOA3NCOA1 | |
| SCHEMBL15741850 | 0.76 | AGTR1 (1.00) | AGTR1RAB9ANPC1NCOA3NCOA1 | |
| SCHEMBL12720904 | 0.75 | MAPT (0.60) | AGTR1RAB9ANPC1SMN1; SMN2HTT | |
| SCHEMBL4035524 | 0.74 | NPC1 (0.62) | RAB9ANPC1SMN1; SMN2HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7928049-B2 | Use of metal complex compounds as oxidation catalysts | BASF SE Ludwigshafen (DE) | 2011-04-19 | — | — | US | disclosed |
| US-7928049-B2 | Use of metal complex compounds as oxidation catalysts | BASF SE Ludwigshafen (DE) | 2011-04-19 | — | — | US | disclosed |
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA CORPORATION (US) | 2011-01-27 | — | — | US | disclosed |
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA CORPORATION (US) | 2011-01-27 | — | — | US | disclosed |
| WO-2009013163-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (CH) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | SOD1, MPO, LPO | AGTR1 2778/4885RAB9A 4379/4885NPC1 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.